Renal handling and physiologic effects of the paramagnetic contrast medium, gadolinium-DOTA.
Katzberg
R W
RW
Department of Radiology, University of Rochester Medical Center, New York.
Sahler
L G
LG
Duda
S W
SW
Morris
T W
TW
McKenna
B A
BA
Pabico
R C
RC
Niedrach
W L
WL
Tonetti
F W
FW
D000818:Animals; D003287:Contrast Media / Q000493:pharmacokinetics* / Q000494:pharmacology; D004285:Dogs; D005682:Gadolinium / Q000493:pharmacokinetics* / Q000494:pharmacology; D006571:Heterocyclic Compounds / Q000493:pharmacokinetics* / Q000494:pharmacology; D007668:Kidney / Q000187:drug effects* / Q000502:physiology; D008279:Magnetic Resonance Imaging; D009942:Organometallic Compounds / Q000493:pharmacokinetics* / Q000494:pharmacology; D013997:Time Factors
D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; C050823:gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate; D005682:Gadolinium